Verrica Pharmaceuticals is an innovative clinical-stage medical dermatology company.
Verrica Pharmaceuticals has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Verrica Pharmaceuticals is headquartered in West Chester, United States.
Verrica Pharmaceuticals is an innovative clinical-stage medical dermatology company.
Verrica Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Verrica Pharmaceuticals — Funding & Investors." VCBacked, November 24, 2025, https://www.vcbacked.co/company/verrica-pharmaceuticals. Accessed August 16, 2026.
VCBacked. (2025). Verrica Pharmaceuticals — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/verrica-pharmaceuticals
{{cite web |title=Verrica Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/verrica-pharmaceuticals |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated